These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
755 related articles for article (PubMed ID: 7530631)
1. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Yarker YE; McTavish D Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study. Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982 [TBL] [Abstract][Full Text] [Related]
4. Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting. Plosker GL; Benfield P Pharmacoeconomics; 1996 Apr; 9(4):357-74. PubMed ID: 10160110 [TBL] [Abstract][Full Text] [Related]
5. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Aksoylar S; Akman SA; Ozgenç F; Kansoy S Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235 [TBL] [Abstract][Full Text] [Related]
6. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy. Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047 [TBL] [Abstract][Full Text] [Related]
7. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Morrow GR; Hickok JT; Rosenthal SN Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429 [TBL] [Abstract][Full Text] [Related]
9. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy. Berrak SG; Ozdemir N; Bakirci N; Turkkan E; Canpolat C; Beker B; Yoruk A Support Care Cancer; 2007 Oct; 15(10):1163-8. PubMed ID: 17372773 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study. Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447 [TBL] [Abstract][Full Text] [Related]
13. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis. Perez EA J Clin Oncol; 1995 Apr; 13(4):1036-43. PubMed ID: 7707101 [TBL] [Abstract][Full Text] [Related]
14. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Markham A; Sorkin EM Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500 [TBL] [Abstract][Full Text] [Related]
15. Ondansetron: a review of its use as an antiemetic in children. Culy CR; Bhana N; Plosker GL Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189 [TBL] [Abstract][Full Text] [Related]
16. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting. Simpson K; Spencer CM; McClellan KJ Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164 [TBL] [Abstract][Full Text] [Related]
17. A narrative review of tropisetron and palonosetron for the control of chemotherapy-induced nausea and vomiting. Yang Y; Zhang L Chin Clin Oncol; 2020 Apr; 9(2):17. PubMed ID: 31865713 [TBL] [Abstract][Full Text] [Related]
18. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood. Phillips RS; Friend AJ; Gibson F; Houghton E; Gopaul S; Craig JV; Pizer B Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007786. PubMed ID: 26836199 [TBL] [Abstract][Full Text] [Related]
19. Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. Italian Group for Antiemetic Research. J Clin Oncol; 1995 Sep; 13(9):2417-26. PubMed ID: 7666102 [TBL] [Abstract][Full Text] [Related]
20. Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials. Vrabel M Clin J Oncol Nurs; 2007 Dec; 11(6):809-13. PubMed ID: 18063539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]